Most important barriers and facilitators of HTA usage in decision-making in Europe

K. L. Cheung*, S. M. A. A. Evers, H. De Vries, P. Levy, S. Pokhrel, T. Jones, M. Danner, J. Wentlandt, L. Knufinke, S. Mayer, M. Hiligsmann

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)297-304
Number of pages8
JournalExpert Review of Pharmacoeconomics & Outcomes Research
Volume18
Issue number3
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • Europe
  • health technology assessment
  • barriers
  • facilitators
  • best-worst
  • HEALTH TECHNOLOGY-ASSESSMENT
  • COST-EFFECTIVENESS ANALYSIS
  • ECONOMIC-EVALUATION
  • RESOURCE-ALLOCATION
  • CARE
  • WORST
  • ASSESSMENTS
  • COUNTRIES
  • IMPACT

Cite this